Compare HROW & WS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HROW | WS |
|---|---|---|
| Founded | 1998 | 1955 |
| Country | United States | United States |
| Employees | 373 | 4800 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 2.0B |
| IPO Year | N/A | 2023 |
| Metric | HROW | WS |
|---|---|---|
| Price | $32.71 | $38.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $69.86 | $42.50 |
| AVG Volume (30 Days) | ★ 887.3K | 194.0K |
| Earning Date | 05-11-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | ★ $3,093,300,000.00 |
| Revenue This Year | $31.62 | $16.77 |
| Revenue Next Year | $50.77 | $2.69 |
| P/E Ratio | ★ N/A | $29.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.53 | $24.36 |
| 52 Week High | $54.98 | $49.17 |
| Indicator | HROW | WS |
|---|---|---|
| Relative Strength Index (RSI) | 40.51 | 53.48 |
| Support Level | $28.54 | $38.01 |
| Resistance Level | $41.67 | $39.29 |
| Average True Range (ATR) | 1.98 | 1.83 |
| MACD | -0.59 | -0.29 |
| Stochastic Oscillator | 33.19 | 41.89 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.